|
1
|
Noor H, Baqai MH, Naveed H, Naveed T,
Rehman SS, Aslam MS, Lakdawala FM, Memon WA, Rani S, Khan H, et al:
Creutzfeldt-Jakob disease: A comprehensive review of current
understanding and research. J Neurol Sci.
467(123293)2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ladogana A, Puopolo M, Croes EA, Budka H,
Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperovitch
A, et al: Mortality from Creutzfeldt-Jakob disease and related
disorders in Europe, Australia, and Canada. Neurology.
64:1586–1591. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ritchie DL and Smith C: Pathological
spectrum of sporadic Creutzfeldt-Jakob disease. Pathology.
57:196–206. 2025.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jurcau MC, Jurcau A, Diaconu RG, Hogea VO
and Nunkoo VS: A systematic review of sporadic Creutzfeldt-Jakob
disease: Pathogenesis, diagnosis, and therapeutic attempts. Neurol
Int. 16:1039–1065. 2024.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hall WA and Masood W: Creutzfeldt-Jakob
disease. In: StatPearls [Internet]. StatPearls Publishing, Treasure
Island, FL, 2025.
|
|
6
|
Appleby BS, Appleby KK and Rabins PV: Does
the presentation of Creutzfeldt-Jakob disease vary by age or
presumed etiology? A meta-analysis of the past 10 years. J
Neuropsychiatry Clin Neurosci. 19:428–435. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Geschwind MD: Rapidly progressive
dementia. Continuum (Minneap Minn). 22:510–537. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Steinhoff BJ, Zerr I, Glatting M,
Schulz-Schaeffer W, Poser S and Kretzschmar HA: Diagnostic value of
periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol.
56:702–708. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Vitali P, MacCagnano E, Caverzasi E, Henry
RG, Haman A, Torres-Chae C, Johnson DY, Miller BL and Geschwind MD:
Diffusion-weighted MRI hyperintensity patterns differentiate CJD
from other rapid dementias. Neurology. 76:1711–1719.
2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Centers for Disease Control and
Prevention: CJD Diagnostic Criteria. Centers for Disease Control
and Prevention, Atlanta, GA, 2024. https://www.cdc.gov/creutzfeldt-jakob/hcp/clinical-overview/diagnosis.html?CDC_AAref_Val=https://www.cdc.gov/prions/cjd/diagnostic-criteria.html.
Accessed July 5, 2025.
|
|
11
|
University of California, San Francisco
(UCSF): Familial Prion Disease. https://memory.ucsf.edu/genetics/familial-prion-disease.
Accessed July 2025.
|
|
12
|
World Medical Association. World Medical
Association Declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194.
2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Puoti G, Bizzi A, Forloni G, Safar JG,
Tagliavini F and Gambetti P: Sporadic human prion diseases:
Molecular insights and diagnosis. Lancet Neurol. 11:618–628.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zerr I, Kallenberg K, Summers DM, Romero
C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B,
Ladogana A, et al: Updated clinical diagnostic criteria for
sporadic Creutzfeldt-Jakob disease. Brain. 132:2659–2668.
2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kaur J, Lam MT, Singh S and Somal NK: Slow
to respond: A rapidly progressive case of sporadic
Creutzfeldt-Jakob disease. Cureus. 16(e53381)2024.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bahrami SN, Karimi AS, Khosravi S and
Almasi-Dooghaee M: Parkinsonism as an initial presentation of
Creutzfeldt-Jakob disease: A case report and review of literature.
Clin Case Rep. 12(e9278)2024.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zitser J, Forner S, Wong K, Chengshi J,
Neuhaus J, Martindale J, Raudabaugh BJ, Benisano K, Goodman-O'Leary
K, Metcalf S, et al: Neuropsychiatric symptoms in sporadic
Creutzfeldt-Jakob disease. Brain: Mar 28, 2025 (Epub ahead of
print).
|
|
18
|
Mader EC, El-Abassi R,
Villemarette-Pittman NR, Santana-Gould L, Olejniczak PW and England
JD: Sporadic Creutzfeldt-Jakob disease with focal findings: Caveats
to current diagnostic criteria. Neurol Int. 5(e1)2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hermann P, Appleby B, Brandel JP, Caughey
B, Collins S, Geschwind MD, Green A, Haïk S, Kovacs GG, Ladogana A,
et al: Biomarkers and diagnostic guidelines for sporadic
Creutzfeldt-Jakob disease. Lancet Neurol. 20:235–246.
2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Frank A, Bendig J, Schnalke N,
Klingelhoefer L, Reichmann H, Akgün K, Ziemssen T and Falkenburger
BH: Serum neurofilament indicates accelerated neurodegeneration and
predicts mortality in late-stage Parkinson's disease. NPJ
Parkinsons Dis. 10(14)2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Baiardi S, Rossi M, Giannini G, Mammana A,
Polischi B, Sambati L, Mastrangelo A, Magliocchetti F, Cortelli P,
Capellari S, et al: Head-to-head comparison of four cerebrospinal
fluid and three plasma neurofilament light chain assays in
Parkinsonism. NPJ Parkinsons Dis. 11(98)2025.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xiang C and Cong S, Tan X, Ma S, Liu Y,
Wang H and Cong S: A meta-analysis of the diagnostic utility of
biomarkers in cerebrospinal fluid in Parkinson's disease. NPJ
Parkinsons Dis. 8(165)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gilman S, Wenning GK, Low PA, Brooks DJ,
Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Dürr A, Fowler CJ,
et al: Second consensus statement on the diagnosis of multiple
system atrophy. Neurology. 71:670–676. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Postuma RB, Poewe W, Litvan I, Lewis S,
Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, et al:
Validation of the MDS clinical diagnostic criteria for Parkinson's
disease. Mov Disord. 33:1601–1608. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Centeno M, Tierney TM, Perani S, Shamshiri
EA, St Pier K, Wilkinson C, Konn D, Vulliemoz S, Grouiller F,
Lemieux L, et al: Combined electroencephalography-functional
magnetic resonance imaging and electrical source imaging improves
localization of pediatric focal epilepsy. Ann Neurol. 82:278–287.
2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Vulliemoz S, Lemieux L, Daunizeau J,
Michel CM and Duncan JS: The combination of EEG source imaging and
EEG-correlated functional MRI to map epileptic networks. Epilepsia.
51:491–505. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Collins S, Boyd A, Fletcher A, Gonzales M,
McLean CA, Byron K and Masters CL: Creutzfeldt-Jakob disease:
Diagnostic utility of 14-3-3 protein immunodetection in
cerebrospinal fluid. J Clin Neurosci. 7:203–208. 2000.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Van Everbroeck B, Boons J and Cras P:
Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin
Neurol Neurosurg. 107:355–360. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Dorey A, Tholance Y, Vighetto A,
Perret-Liaudet A, Lachman I, Krolak-Salmon P, Wagner U, Struyfs H,
De Deyn PP, El-Moualij B, et al: Association of cerebrospinal fluid
prion protein levels and the distinction between Alzheimer disease
and Creutzfeldt-Jakob disease. JAMA Neurol. 72:267–275.
2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Otto M, Wiltfang J, Tumani H, Zerr I,
Lantsch M, Kornhuber J, Weber T, Kretzschmar HA and Poser S:
Elevated levels of tau-protein in cerebrospinal fluid of patients
with Creutzfeldt-Jakob disease. Neurosci Lett. 225:210–212.
1997.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Foutz A, Appleby BS, Hamlin C, Liu X, Yang
S, Cohen Y, Chen W, Blevins J, Fausett C, Wang H, et al: Diagnostic
and prognostic value of human prion detection in cerebrospinal
fluid. Ann Neurol. 81:79–92. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Dalmau J, Lancaster E, Martinez-Hernandez
E, Rosenfeld MR and Balice-Gordon R: Clinical experience and
laboratory investigations in patients with anti-NMDAR encephalitis.
Lancet Neurol. 10:63–74. 2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Atarashi R, Satoh K, Sano K, Fuse T,
Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamanaka H,
Shirabe S, et al: Ultrasensitive human prion detection in
cerebrospinal fluid by real-time quaking-induced conversion. Nat
Med. 17:175–178. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
Kuzkina A, Bargar C, Schmitt D, Rößle J,
Wang W, Schubert AL, Tatsuoka C, Gunzler SA, Zou WQ, Volkmann J, et
al: Diagnostic value of skin RT-QuIC in Parkinson's disease: A
two-laboratory study. NPJ Parkinsons Dis. 7(99)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Senesi M, Lewis V, Varghese S, Stehmann C,
McGlade A, Doecke JD, Ellett L, Sarros S, Fowler CJ, Masters CL, et
al: Diagnostic performance of CSF biomarkers in a
well-characterized Australian cohort of sporadic Creutzfeldt-Jakob
disease. Front Neurol. 14(1072952)2023.PubMed/NCBI View Article : Google Scholar
|
